Automatic and Manual Image Fusion of In-pentetreotide SPECT and Diagnostic CT in Neuroendocrine Tumor Imaging - An Evaluation

Overview

Journal J Med Phys

Date 2010 Dec 21

PMID 21170187

Authors

Elisabeth Hedlund

Jan-Erik Karlsson

Sven-Ake Starck

Affiliations

Soon will be listed here.

Abstract

In the clinical diagnosis of neuroendocrine tumors (NET), the results of examinations, such as high-resolution computed tomography (CT) and single photon computerized tomography (SPECT), have conventionally been interpreted separately. The aim of the present study was to evaluate Hermes Multimodality™ 5.0 H Image Fusion software-based automatic and manual image fusion of SPECT and CT for the localization of NET lesions. Out of 34 NET patients who were examined by means of somatostatin receptor scintigraphy (SRS) with 111In- pentetreotide along with SPECT, 22 patients had a CT examination of the abdomen, which was used in the fusion analysis. SPECT and CT data were fused using software with a registration algorithm based on normalized mutual information. The criteria for acceptable fusion were established at a maximum cranial or caudal dislocation of 25 mm between the images and at a reasonable consensus (in order of less than 1 cm) between outline of the reference organs. The automatic fusion was acceptable in 13 of the 22 examinations, whereas 9 fusions were not. However all the 22 examinations were acceptable at the manual fusion. The result of automatic fusion was better when the slice thickness of 5 mm was applied at CT examination, when the number of slices was below 100 in CT data and when both examinations included uptakes of pathological lesions. Retrospective manual image fusion of SPECT and CT is a relatively inexpensive but reliable method to be used in NET imaging. Automatic image fusion with specified software of SPECT and CT acts better when the number of CT slices is reduced to the SPECT volume and when corresponding pathological lesions appear at both SPECT and CT examinations.

References

Perri M, Erba P, Volterrani D, Lazzeri E, Boni G, Grosso M . Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors. Q J Nucl Med Mol Imaging. 2008; 52(4):323-33. View

Even-Sapir E, Keidar Z, SACHS J, Engel A, Bettman L, Gaitini D . The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. J Nucl Med. 2001; 42(7):998-1004. View

Gabriel M, Hausler F, Bale R, Moncayo R, Decristoforo C, Kovacs P . Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours. Eur J Nucl Med Mol Imaging. 2005; 32(12):1440-51. DOI: 10.1007/s00259-005-1875-z. View

Israel O, Keidar Z, Iosilevsky G, Bettman L, SACHS J, Frenkel A . The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med. 2001; 31(3):191-205. DOI: 10.1053/snuc.2001.23525. View

Amthauer H, Denecke T, Rohlfing T, Ruf J, Bohmig M, Gutberlet M . Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours. Eur Radiol. 2005; 15(7):1456-62. DOI: 10.1007/s00330-004-2590-z. View

Keidar Z, Israel O, Krausz Y . SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med. 2003; 33(3):205-18. DOI: 10.1053/snuc.2003.127310. View

Castaldi P, Rufini V, Treglia G, Bruno I, Perotti G, Stifano G . Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours. Radiol Med. 2008; 113(7):1056-67. DOI: 10.1007/s11547-008-0319-9. View

OConnor M, Kemp B . Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations. Semin Nucl Med. 2006; 36(4):258-66. DOI: 10.1053/j.semnuclmed.2006.05.005. View

Amthauer H, Ruf J, Bohmig M, Lopez-Hanninen E, Rohlfing T, Wernecke K . Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit?. Eur J Nucl Med Mol Imaging. 2003; 31(3):342-8. DOI: 10.1007/s00259-003-1379-7. View

10.

Krausz Y, Keidar Z, Kogan I, Even-Sapir E, Bar-Shalom R, Engel A . SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf). 2003; 59(5):565-73. DOI: 10.1046/j.1365-2265.2003.01885.x. View

11.

Townsend D . Multimodality imaging of structure and function. Phys Med Biol. 2008; 53(4):R1-R39. DOI: 10.1088/0031-9155/53/4/R01. View

12.

Wells 3rd W, Viola P, Atsumi H, Nakajima S, Kikinis R . Multi-modal volume registration by maximization of mutual information. Med Image Anal. 1996; 1(1):35-51. DOI: 10.1016/s1361-8415(01)80004-9. View

13.

Hutton B, Braun M . Software for image registration: algorithms, accuracy, efficacy. Semin Nucl Med. 2003; 33(3):180-92. DOI: 10.1053/snuc.2003.127309. View

14.

Schillaci O . Functional-anatomical image fusion in neuroendocrine tumors. Cancer Biother Radiopharm. 2004; 19(1):129-34. DOI: 10.1089/108497804773391775. View

15.

Slomka P . Software approach to merging molecular with anatomic information. J Nucl Med. 2004; 45 Suppl 1:36S-45S. View